SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-17-034056
Filing Date
2017-05-19
Accepted
2017-05-19 16:34:20
Documents
1
Group Members
JOHN S. STAFFORD, IIISTEPHEN WHITESW INVESTMENT MANAGEMENT LLCSWIM PARTNERS LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a17-13892_1sc13da.htm SC 13D/A 151406
  Complete submission text file 0001104659-17-034056.txt   153183
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Subject) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-37393 | Film No.: 17858359
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 350 N. ORLEANS, SUITE 2N CHICAGO IL 60654
Business Address 350 N. ORLEANS, SUITE 2N CHICAGO IL 60654 312-244-5284
Ronin Capital, LLC (Filed by) CIK: 0001512282 (see all company filings)

IRS No.: 364472500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A